These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14989925)

  • 1. [The diagnostic value of 34 betaE 12 in differential diagnosis of benign and malignant mammary lesions].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):31-5. PubMed ID: 14989925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of immunocytochemistry in fine needle aspiration cytology diagnosis of mammary lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):738-43. PubMed ID: 17374259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
    Zhang JL; Zhang HY; Wei B; Lang ZQ; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
    Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
    Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
    Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
    Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconclusive or erroneous fine-needle aspirates of breast with adequate and representative material: a cytologic/histologic study.
    Shabb NS; Boulos FI; Chakhachiro Z; Abbas J; Abdul-Karim FW
    Diagn Cytopathol; 2014 May; 42(5):405-15. PubMed ID: 24167007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
    MacGrogan G
    Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
    [No Abstract]   [Full Text] [Related]  

  • 15. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic presentation of mammary carcinoma on aspiration biopsy smears.
    Wallgren A; Zajicek J
    Acta Cytol; 1976; 20(5):469-78. PubMed ID: 185869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
    Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
    Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.